ArticleJournal of carcinogenesis2006

Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways.

Bodo Schniewind et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.